Thierry Laugel
Board Member
Medicine
Blink Biomedical
France
Biography
Japan and research programmes were being rolled out with Grelan, a Takeda Group company. Having then studied at Insead, he joined Flamel Technologies as project director for Pharmaceutical R&D, after its IPO on the Nasdaq. In 1998, Thierry then moved to the investment world, first at Caisse des Dépôts (CDC Innovation, then within the PharmaVent project), before moving to AGF Private Equity, where he supervised the healthcare investment team.
Research Interest
Medicine,Pharmacology in Medicne
